InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-10.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Simmons Jeffrey N, Chairman & CEO. Director active across 2 companies, notably Elanco Animal Health Inc. In total, 22 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €2.6m. Activity tracked since 11 August 2021. The latest transaction was filed on 3 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
265,252 shares0Common StockSEC:0001415889-25-007082:0
75,721 shares@ US$11.1716.2% of flowCommon StockSEC:0001415889-25-006627:0
449,408 shares0Common StockSEC:0001415889-25-005164:0
100,000 shares@ US$13.006123.7% of flowCommon StockSEC:0001415889-24-021121:0
Ideal exit: 9 May 2025 (T+270)
11,012 shares@ US$15.993.2% of flowCommon StockSEC:0001415889-24-007220:0
187,150 shares0Common StockSEC:0001415889-24-006648:0
148,084 shares0Common StockSEC:0001415889-24-005975:0
15,000 shares@ US$9.59812.7% of flowCommon StockSEC:0001415889-23-004744:0
Ideal exit: 5 Dec 2023 (T+270)
10,696 shares@ US$11.102.2% of flowCommon StockSEC:0001415889-23-004468:0
316,386 shares0Common StockSEC:0001415889-23-004353:0
12,662 shares@ US$11.262.7% of flowCommon StockSEC:0001415889-23-004289:0
30,000 shares@ US$14.53828.7% of flowCommon StockSEC:0001415889-22-009497:0
Ideal exit: 6 Jun 2023 (T+270)
10,688 shares@ US$27.950.0027% mcap13.3% of flowCommon StockSEC:0001415889-22-002744:0
88,114 shares0Common StockSEC:0001415889-22-002472:0
229,655 shares0Common StockSEC:0001179110-22-001597:0
15,814 shares@ US$33.660.0046% mcap22.4% of flowCommon StockSEC:0001179110-21-009594:0
15,814 shares@ US$33.669.1% of flowCommon StockSEC:0001179110-21-009594
16,850 shares@ US$29.708.5% of flowCommon StockSEC:0000950138-21-000410
Ideal exit: 8 May 2022 (T+270)
16,850 shares@ US$29.700.0043% mcap20.9% of flowCommon StockSEC:0000950138-21-000410:0
Ideal exit: 8 May 2022 (T+270)
9,843 sharesCommon StockSEC:0000059478-16-000310:0
4,553 sharesCommon StockSEC:0000059478-16-000310:1
19,344 sharesCommon StockSEC:0000059478-16-000270:0
22 of 22 declarations
About Simmons Jeffrey N
Jeffrey N. Simmons is the President, CEO & Director at Elanco Animal Health Inc. In this role, he is responsible for the strategic leadership of the company, including operations and product development. With extensive experience in the animal health sector, he guides the company towards innovation and growth. His leadership is essential for achieving the organization's objectives and strengthening its market position.
